Loriane Gutermann

807 total citations
18 papers, 200 citations indexed

About

Loriane Gutermann is a scholar working on Rheumatology, Immunology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Loriane Gutermann has authored 18 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Immunology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Loriane Gutermann's work include Biosimilars and Bioanalytical Methods (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Pharmaceutical studies and practices (4 papers). Loriane Gutermann is often cited by papers focused on Biosimilars and Bioanalytical Methods (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Pharmaceutical studies and practices (4 papers). Loriane Gutermann collaborates with scholars based in France, Canada and United Kingdom. Loriane Gutermann's co-authors include Maxime Dougados, Anna Moltó, Yannick Allanore, Ornella Conort, Christian Roux, Claire Le Jeunne, Xavier Romand, Maryse Mézières, Catherine Beauvais and Sophie Pouplin and has published in prestigious journals such as Annals of the Rheumatic Diseases, Seminars in Arthritis and Rheumatism and The Journal of Clinical Pharmacology.

In The Last Decade

Loriane Gutermann

16 papers receiving 194 citations

Peers

Loriane Gutermann
Saman K. Hashmi United States
Shreeya Tewary United Kingdom
Anne Des Roches Canada
Daniel Sumpton Australia
Jonathan Coblyn United States
Sarah Wall United States
Ilais Moreno Velásquez Panama
Michelle Luo United States
C. K. Daugherty United States
Richard Veselý United States
Saman K. Hashmi United States
Loriane Gutermann
Citations per year, relative to Loriane Gutermann Loriane Gutermann (= 1×) peers Saman K. Hashmi

Countries citing papers authored by Loriane Gutermann

Since Specialization
Citations

This map shows the geographic impact of Loriane Gutermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loriane Gutermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loriane Gutermann more than expected).

Fields of papers citing papers by Loriane Gutermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loriane Gutermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loriane Gutermann. The network helps show where Loriane Gutermann may publish in the future.

Co-authorship network of co-authors of Loriane Gutermann

This figure shows the co-authorship network connecting the top 25 collaborators of Loriane Gutermann. A scholar is included among the top collaborators of Loriane Gutermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loriane Gutermann. Loriane Gutermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stéphan, François, Loriane Gutermann, Sarah Djabarouti, et al.. (2023). Real‐World Experience with a Human Fibrinogen Concentrate: Clinical Data from Adult and Pediatric Patients Requiring Fibrinogen for Bleeding Control and Prevention. The Journal of Clinical Pharmacology. 63(11). 1186–1196.
2.
Singh, Sally, et al.. (2021). Amélioration des connaissances des patients traités par un anticoagulant oral après avoir bénéficié d’un entretien pharmaceutique à l’hôpital. Annales Pharmaceutiques Françaises. 80(4). 467–477. 1 indexed citations
3.
Gutermann, Loriane, et al.. (2021). Impact of a pharmacist-led programme on biologics knowledge and adherence in patients with spondyloarthritis. Clinical and Experimental Rheumatology. 39(4). 811–818. 9 indexed citations
4.
Moltó, Anna, Véred Abitbol, Loriane Gutermann, et al.. (2020). Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice. Seminars in Arthritis and Rheumatism. 50(6). 1449–1456. 30 indexed citations
5.
Gutermann, Loriane, Jérôme Avouac, Claire Goulvestre, et al.. (2020). Variation du taux d’anticorps anti-peptide citrulliné après un traitement par abatacept en comparaison au rituximab et anti-TNFa. Revue du Rhumatisme. 87. A120–A120.
6.
7.
Romand, Xavier, Anna Moltó, René‐Marc Flipo, et al.. (2019). SAT0629 THERE ARE 4 MAIN QUESTIONNAIRES TO ASSESS ADHERENCE IN INFLAMMATORY ARTHRITIS BUT NONE OF THEM PERFORM WELL: A SYSTEMATIC LITERATURE REVIEW. Annals of the Rheumatic Diseases. 78. 1411–1411. 3 indexed citations
8.
Moltó, Anna, Véred Abitbol, Loriane Gutermann, et al.. (2019). OP0227 EFFECTS OF SUCCESSIVE SWITCHES TO DIFFERENT BIOSIMILARS INFLIXIMAB ON IMMUNOGENICITY IN CHRONIC INFLAMMATORY DISEASES IN DAILY CLINICAL PRACTICE. Annals of the Rheumatic Diseases. 78. 190–191. 1 indexed citations
9.
Gutermann, Loriane, et al.. (2019). SAT0130 ANTI-CITRULLINATED PEPTIDE ANTI-BODIES TITERS DECREASE AFTER RITUXIMAB BUT NOT AFTER ABATACEPT OR TNF BLOCKERS TREATMENT: A REAL-LIFE ANALYSIS. Annals of the Rheumatic Diseases. 78. 1134–1134. 1 indexed citations
10.
11.
Romand, Xavier, Laure Gossec, Sophie Pouplin, et al.. (2018). Methods to improve medication adherence in patients with chronic inflammatory rheumatic diseases: a systematic literature review. RMD Open. 4(2). e000684–e000684. 37 indexed citations
12.
Avouac, Jérôme, Anna Moltó, Véred Abitbol, et al.. (2017). Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France. Seminars in Arthritis and Rheumatism. 47(5). 741–748. 59 indexed citations
13.
Avouac, Jérôme, Anna Moltó, Véred Abitbol, et al.. (2017). SAT0163 Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory rheumatic diseases in daily clinical practice: the experience of cochin hospital, paris, france. Annals of the Rheumatic Diseases. 76. 831–832. 2 indexed citations
14.
15.
Gutermann, Loriane, et al.. (2016). Conciliation médicamenteuse d’entrée en milieu hospitalier : intérêt du dossier pharmaceutique. Le Pharmacien Hospitalier et Clinicien. 51(1). 67–68. 1 indexed citations
16.
Gutermann, Loriane, et al.. (2016). Création d’un jeu d’éducation thérapeutique pour les patients atteints de rhumatismes inflammatoires chroniques. Le Pharmacien Hospitalier et Clinicien. 51(4). 364–365. 1 indexed citations
17.
Gutermann, Loriane, et al.. (2014). Reducing medication errors at admission: 3 cycles to implement, improve and sustain medication reconciliation. International Journal of Clinical Pharmacy. 37(1). 113–120. 20 indexed citations
18.
Gutermann, Loriane, et al.. (2014). Parents and carers of patients who had liver transplants: opinions and experiences of medication issues. European Journal of Hospital Pharmacy. 21(6). 339–343. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saman K. Hashmi Breakdown of academic impact, for papers by Shreeya Tewary Breakdown of academic impact, for papers by Anne Des Roches Breakdown of academic impact, for papers by Daniel Sumpton Breakdown of academic impact, for papers by Jonathan Coblyn Breakdown of academic impact, for papers by Sarah Wall Breakdown of academic impact, for papers by Ilais Moreno Velásquez Breakdown of academic impact, for papers by Michelle Luo Breakdown of academic impact, for papers by C. K. Daugherty Breakdown of academic impact, for papers by Richard Veselý
Rankless by CCL
2026